ANI Pharmaceuticals, Inc. revenue breakdown overview

ANI Pharmaceuticals, Inc. revenue for the last year amounted to 486.82 M USD, the most of which — 374.70 M USD — came from its highest performing source at the moment, Generics, Established Brands, and Other, the year earlier bringing 274.70 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought ANI Pharmaceuticals, Inc. 486.25 M USD, and the year before that — 312.43 M USD.